logo-loader

Deltex Medical puts brain oxygen monitor on product roster

Last updated: 17:59 19 Jan 2015 AEDT, First published: 18:59 19 Jan 2015 AEDT

brain_350_54bcbb0fdf7e5

Deltex Medical (LON:DEMG) has taken on the UK distributorship of a non-invasive brain monitor to broaden its product range.

The oesophageal Doppler blood flow monitoring specialist has signed an exclusive deal with CAS Medical Systems’ FORE-SIGHT to sell its cerebral oximeter monitors in the UK and Ireland.

Used primarily in cardiac surgery, these monitors alert doctors when levels of oxygen in the brain reach dangerously high levels.

The UK market is worth £1mln annually with FORE-SIGHT accounting for a fifth of that in 2014.

CASMED is NASDAQ-listed and approximately two-thirds of its growth currently is in the US and it expects the tie-up with Deltex to boost UK sales.

Thomas Patton, CASMED’s president and chief executive, said: “With a sales channel to over 90% of major UK hospitals supported by a full national team of sales representatives and clinical support personnel, Deltex has excellent penetration and relationships in hospitals that are likely users of FORE-SIGHT."

Ewan Phillips, Deltex Medical's chief executive, said: "Cerebral oximetry is a complementary technology to our haemodynamic monitoring products."

Poseidon Nickel signs binding agreement with Mineral Resources to divest...

Departing Poseidon Nickel Ltd (ASX:POS, OTC:PSDNF) CEO Craig Jones and incoming CEO Brendan Shalders join Proactive’s Jonathan Jackson to discuss the divestment of Lake Johnston to Mineral Resources Ltd (ASX:MIN). Jones, who has played a pivotal role in this strategic move, shared insights on...

3 hours, 58 minutes ago